Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
Hill JA, Menon MP, Dhanireddy S, Wurfel MM, Green M, Jain R, Chan JD, Huang J, Bethune D, Turtle C, Johnston C, Xie H, Leisenring WM, Nina Kim H, Cheng GS.
Hill JA, et al.
J Med Virol. 2021 Apr;93(4):2270-2280. doi: 10.1002/jmv.26674. Epub 2020 Nov 22.
J Med Virol. 2021.
PMID: 33200828
Free PMC article.